A detailed history of Nuveen Asset Management, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 181,339 shares of HAE stock, worth $14.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
181,339
Previous 181,799 0.25%
Holding current value
$14.9 Million
Previous $15 Million 3.1%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.45 - $91.58 $33,327 - $42,126
-460 Reduced 0.25%
181,339 $14.6 Million
Q2 2024

Aug 09, 2024

BUY
$81.24 - $97.37 $156,955 - $188,118
1,932 Added 1.07%
181,799 $15 Million
Q1 2024

May 13, 2024

BUY
$71.24 - $85.35 $4,345 - $5,206
61 Added 0.03%
179,867 $15.4 Million
Q4 2023

Feb 14, 2024

BUY
$80.59 - $92.61 $163,839 - $188,276
2,033 Added 1.14%
179,806 $15.4 Million
Q3 2023

Nov 14, 2023

SELL
$82.56 - $93.49 $15,191 - $17,202
-184 Reduced 0.1%
177,773 $15.9 Million
Q2 2023

Aug 14, 2023

BUY
$80.84 - $89.45 $488,111 - $540,099
6,038 Added 3.51%
177,957 $15.2 Million
Q1 2023

May 15, 2023

SELL
$72.75 - $90.6 $1.68 Million - $2.09 Million
-23,092 Reduced 11.84%
171,919 $14.2 Million
Q4 2022

Feb 14, 2023

BUY
$73.85 - $86.14 $269,921 - $314,841
3,655 Added 1.91%
195,011 $15.3 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $401,955 - $499,491
6,350 Added 3.43%
191,356 $14.2 Million
Q2 2022

Aug 15, 2022

SELL
$49.27 - $66.08 $272,216 - $365,092
-5,525 Reduced 2.9%
185,006 $12.1 Million
Q1 2022

May 16, 2022

BUY
$43.77 - $63.22 $6,696 - $9,672
153 Added 0.08%
190,531 $10.6 Million
Q4 2021

Feb 14, 2022

SELL
$49.55 - $74.59 $1.29 Million - $1.94 Million
-25,956 Reduced 12.0%
190,378 $10.1 Million
Q3 2021

Nov 12, 2021

SELL
$57.6 - $70.59 $2.16 Million - $2.64 Million
-37,440 Reduced 14.75%
216,334 $15.3 Million
Q2 2021

Aug 16, 2021

BUY
$51.81 - $118.56 $3.44 Million - $7.87 Million
66,413 Added 35.45%
253,774 $16.9 Million
Q1 2021

May 17, 2021

SELL
$111.01 - $139.48 $1.94 Million - $2.43 Million
-17,435 Reduced 8.51%
187,361 $20.8 Million
Q4 2020

May 17, 2021

SELL
$88.75 - $119.95 $841,705 - $1.14 Million
-9,484 Reduced 4.43%
204,796 $24.3 Million
Q4 2020

Feb 16, 2021

BUY
$88.75 - $119.95 $6.16 Million - $8.33 Million
69,443 Added 47.95%
214,280 $25.4 Million
Q3 2020

Nov 16, 2020

SELL
$75.65 - $93.58 $1.11 Million - $1.37 Million
-14,629 Reduced 9.17%
144,837 $12.6 Million
Q2 2020

Aug 14, 2020

SELL
$84.96 - $118.91 $27.8 Million - $38.9 Million
-326,919 Reduced 67.21%
159,466 $14.3 Million
Q1 2020

May 14, 2020

BUY
$74.34 - $121.82 $12.2 Million - $20.1 Million
164,741 Added 51.22%
486,385 $48.5 Million
Q4 2019

Feb 14, 2020

SELL
$114.37 - $129.46 $5.05 Million - $5.72 Million
-44,177 Reduced 12.08%
321,644 $37 Million
Q3 2019

Nov 14, 2019

SELL
$117.16 - $138.52 $6.42 Million - $7.59 Million
-54,758 Reduced 13.02%
365,821 $46.1 Million
Q2 2019

Aug 15, 2019

BUY
$81.74 - $120.34 $34.4 Million - $50.6 Million
420,579 New
420,579 $50.6 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.22B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.